Detalles de la búsqueda
1.
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials.
Lancet
; 394(10209): 1638-1650, 2019 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31543428
2.
Assessing the burden of treatment-emergent adverse events associated with atypical antipsychotic medications.
BMC Psychiatry
; 17(1): 67, 2017 02 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-28193195
3.
Impact of natalizumab on patient-reported outcomes in multiple sclerosis: a longitudinal study.
Health Qual Life Outcomes
; 10: 155, 2012 Dec 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-23270428
4.
Costs associated with unplanned readmissions among patients with heart failure with and without hyponatremia.
Am J Health Syst Pharm
; 76(6): 374-380, 2019 02 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31361839
5.
Prevalence and humanistic impact of potential misdiagnosis of bipolar disorder among patients with major depressive disorder in a commercially insured population.
J Manag Care Pharm
; 14(7): 631-42, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18774873
6.
Relapse prevention: a cost-effectiveness analysis of brexpiprazole treatment in adult patients with schizophrenia in the USA.
Clinicoecon Outcomes Res
; 10: 443-456, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30147350
7.
Utilization and budget impact of tolvaptan in the inpatient setting among patients with heart failure and hyponatremia.
Curr Med Res Opin
; 34(3): 559-566, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29297709
8.
Cost-effectiveness of brexpiprazole adjunctive treatment for major depressive disorder.
J Affect Disord
; 207: 54-62, 2017 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27693466
9.
Statin safety: an assessment using an administrative claims database.
Am J Cardiol
; 97(8A): 61C-68C, 2006 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-16581331
10.
Inpatient resource use and costs associated with switching from oral antipsychotics to aripiprazole once-monthly for the treatment of schizophrenia.
Drugs Context
; 5: 212273, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27114739
11.
Pharmacoeconomic comparison of aripiprazole once-monthly and paliperidone palmitate from a head-to-head clinical trial in schizophrenia: a US analysis.
Drugs Context
; 5: 212301, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27708677
12.
Hospital Readmission Rates Among Patients With Schizophrenia Treated With Long-Acting Injectables or Oral Antipsychotics.
Psychiatr Serv
; 67(11): 1183-1188, 2016 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27417897
13.
The Economic Burden of Schizophrenia in the United States in 2013.
J Clin Psychiatry
; 77(6): 764-71, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-27135986
14.
Reduction in inpatient resource utilization and costs associated with long-acting injectable antipsychotics across different age groups of Medicaid-insured schizophrenia patients.
Drugs Context
; 42015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25834621
15.
Lack of tolerable treatment options for patients with schizophrenia.
Neuropsychiatr Dis Treat
; 11: 3095-104, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26719694
16.
Prevalence of pre-existing risk factors for adverse events associated with atypical antipsychotics among commercially insured and medicaid insured patients newly initiating atypical antipsychotics.
Curr Drug Saf
; 9(3): 227-35, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24909573
17.
Cost-effectiveness of aripiprazole once-monthly compared with paliperidone palmitate once-monthly injectable for the treatment of schizophrenia in the United States.
J Med Econ
; 17(8): 567-76, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24758296
18.
Risk of hospitalized rhabdomyolysis associated with lipid-lowering drugs in a real-world clinical setting.
J Clin Lipidol
; 7(2): 102-8, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23415428
19.
Adherence to single-pill combination versus multiple-pill combination lipid-modifying therapy among patients with mixed dyslipidemia in a managed care population.
Curr Med Res Opin
; 27(5): 961-8, 2011 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-21381893
20.
Impact of natalizumab on patient-reported outcomes in a clinical practice setting: a cross-sectional survey.
Patient
; 2(2): 105-12, 2009 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22273086
Resultados
1 -
20
de 20
1
Próxima >
>>